The Clorox Company (NYSE:CLX) Holdings Decreased by LVM Capital Management Ltd. MI

LVM Capital Management Ltd. MI lessened its stake in The Clorox Company (NYSE:CLX) by 5.2% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 3,266 shares of the company’s stock after selling 180 shares during the quarter. LVM Capital Management Ltd. MI’s holdings in Clorox were worth $530,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. State Street Corp boosted its holdings in shares of Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after acquiring an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC boosted its stake in Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after purchasing an additional 4,490,421 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Clorox by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after purchasing an additional 33,970 shares during the period. Stifel Financial Corp raised its stake in shares of Clorox by 1.7% in the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after buying an additional 37,967 shares in the last quarter. Finally, Nuance Investments LLC lifted its holdings in shares of Clorox by 150.6% in the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after buying an additional 960,094 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Down 2.0 %

Shares of NYSE:CLX traded down $3.14 during midday trading on Friday, hitting $157.49. 346,783 shares of the stock were exchanged, compared to its average volume of 958,316. The business’s fifty day simple moving average is $164.76 and its two-hundred day simple moving average is $155.41. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a market capitalization of $19.49 billion, a PE ratio of 54.87, a P/E/G ratio of 3.04 and a beta of 0.42.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the company earned $0.49 earnings per share. The business’s revenue was up 27.0% compared to the same quarter last year. As a group, research analysts predict that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.10%. Clorox’s payout ratio is presently 170.03%.

Analysts Set New Price Targets

A number of analysts recently commented on CLX shares. DA Davidson boosted their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and increased their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Barclays increased their price target on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday, November 1st. Finally, Wells Fargo & Company upgraded Clorox from an “underweight” rating to an “equal weight” rating and boosted their price objective for the stock from $155.00 to $157.00 in a report on Tuesday. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Clorox presently has a consensus rating of “Hold” and a consensus price target of $157.46.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.